Tiburon, CA, United States of America

Robert Jaffe

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Jaffe. Retrieved from https://idiyas.com/inventor/robert-jaffe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Jaffe

Introduction

Robert Jaffe is a notable inventor based in Tiburon, California. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on methods to combat cancer by utilizing specific pharmaceutical compositions.

Latest Patents

Jaffe holds a patent for a method of treating cancer with a VEGF antagonist and an anti-proliferative agent. This patent, titled "Methods of treating cancer and/or reducing or inhibiting tumor growth in a subject in need thereof," involves administering a pharmaceutical composition that includes a vascular endothelial cell growth factor (VEGF) antagonist, such as a VEGF trap, along with an anti-proliferative agent, such as taxol, and a pharmaceutically acceptable carrier. He has 1 patent to his name.

Career Highlights

Robert Jaffe is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to advance his research in oncology. His work has been instrumental in developing new therapeutic strategies for cancer patients.

Collaborations

Some of his notable coworkers include Jocelyn Holash and Limin Hu, who have collaborated with him on various projects aimed at improving cancer treatment methodologies.

Conclusion

Robert Jaffe's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to pave the way for advancements in oncology and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…